Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs

Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs

Background. To explore clinical characteristics and treatment reasons for intravitreal injection of antivascular endothelial growth factor (anti-VEGF) drugs in the treatment of nontype 1 retinopathy of prematurity (ROP). Methods. A retrospective study was conducted to screen the nontype 1 ROP from t...

Full description

Bibliographic Details
Main Authors:	Haitao Zhang, Xin Yang, Fangfang Zheng, Xiangke Yin, Suhua Wan
Format:	Article
Language:	English
Published:	Hindawi Limited 2022-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2022/6266528

Similar Items

The efficacy of intravitreal antivascular endothelial growth factor as primary treatment of retinopathy of prematurity: Experience from a tertiary hospital
by: H Kana, et al.
Published: (2017-03-01)

Acute renal failure after intravitreal antivascular endothelial growth factor therapy
by: Yu-Fang Huang, et al.
Published: (2017-06-01)

Association between the response of intravitreal antivascular endothelial growth factor injection and systemic factors of diabetic macular edema
by: So Hyung Lee, et al.
Published: (2024-04-01)

Vascularization of intravitreal injection of Conbercept in the treatment of retinopathy of prematurity
by: Zheng Fu, et al.
Published: (2023-03-01)

Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity
by: Caifeng Gao, et al.
Published: (2023-05-01)

Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
by: Nada O. Taher, et al.
Published: (2022-05-01)

Evaluation of the effect of intravitreal antivascular endothelial growth factor versus medical treatment in acute central serous chorioretinopathy
by: Moataz A Sallam
Published: (2022-01-01)

Comparison of intravitreal injection of Ranibizumab versus Conbercept in the treatment of retinopathy of prematurity
by: Chen Juan, et al.
Published: (2024-05-01)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
by: Sadik Gorkem Cevik, et al.
Published: (2020-08-01)

Reactivation of retinopathy of prematurity after intravitreal bevacizumab monotherapy in aggressive posterior retinopathy of prematurity
by: Ritesh Verma, et al.
Published: (2023-01-01)

Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity
by: Ching-Yen Huang, et al.
Published: (2022-11-01)

Role of deferred retinal laser following intravitreal injection of bevacizumab in treatment of severe retinopathy of prematurity
by: Vishalakshi Bhat, et al.
Published: (2023-01-01)

Efficacy of Intravitreal injection of 2-Methoxyestradiol in regression of neovascularization of a retinopathy of prematurity rat model
by: Azza Mohamed Ahmed Said, et al.
Published: (2017-04-01)

Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity
by: Neelam Pawar, et al.
Published: (2023-01-01)

Intravitreal ranibizumab for postlaser anterior segment ischemia in retinopathy of prematurity
by: Vasumathy Vedantham
Published: (2022-01-01)

Efficacy and safety profile of intravitreal dexamethasone implant versus antivascular endothelial growth factor treatment in diabetic macular edema: a systematic review and meta-analysis
by: Sheng-Chu Chi, et al.
Published: (2023-05-01)

Tape, fix, and inject: a novel one-person technique of intravitreal injection for the treatment of retinopathy of prematurity under topical anesthesia
by: Islam S.H Ahmed, et al.
Published: (2023-01-01)

Progress of anti-vascular endothelial growth factor drugs for the treatment of retinopathy of prematurity
by: Tong Ding, et al.
Published: (2023-08-01)

Intravitreal ranibizumab for retinopathy of prematurity: The ocular and systemic safety profile query
by: Khulood Al Kalbani, et al.
Published: (2023-01-01)

Antivascular endothelial growth factor in treatment of choroidal osteoma not associated with choroidal neovascular membrane
by: Thomas Cherian, et al.
Published: (2017-01-01)

Vascular endothelial growth factor inhibitors for retinopathy of prematurity
by: O.V. Zhukova, et al.
Published: (2020-11-01)

A new, theoretically safer method of intravitreal injection of bevacizumab in progressive retinopathy of prematurity using scleral trans-illumination.
by: Patel, C, et al.
Published: (2010)

Efficacy of intravitreal bevacizumab for the treatment of Zone I Type 1 retinopathy of prematurity
by: Reza Karkhaneh, et al.
Published: (2018-01-01)

Short-term effects of intravitreal anti-vascular endothelial growth factor agents on body weight and multiple systems after treatment for retinopathy of prematurity
by: Jing Chen, et al.
Published: (2023-01-01)

Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea
by: Hyeon-Jeong Lee, et al.
Published: (2023-12-01)

The effect of intravitreal bevacizumab injection on the corneal endothelial cells
by: Akbar Derakhshan, et al.
Published: (2016-04-01)

Revascularization of immature retinas with retinopathy of prematurity using combination therapy of deferred laser treatment after a single intravitreal bevacizumab injection
by: Ju Seouk Lee, et al.
Published: (2023-03-01)

Long-term peripheral retinal vascular behavior in retinopathy of prematurity patients treated with ranibizumab intravitreal injection as monotherapy using fluorescein angiography
by: Raghad Al Rasheed, et al.
Published: (2022-08-01)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
by: Casey C. Bunge, MD, et al.
Published: (2023-12-01)

Recurrence risk factors of intravitreal ranibizumab monotherapy in retinopathy of prematurity: a retrospective study at one center
by: Feng-Yue Wu, et al.
Published: (2023-01-01)

Comparison of intravitreal injection of ranibizumab versus bevacizumab for treatment of type 1 and aggressive retinopathy of prematurity in rural Egypt. A randomized clinical trial
by: Ghada Mahmoud Tawfik, et al.
Published: (2022-10-01)

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
by: Tzu-Yi Lin, et al.
Published: (2023-02-01)

Effect of vitrectomy with intravitreal injection of triamcinolone acetonide in the treatment of proliferative diabetic retinopathy
by: Heng Li, et al.
Published: (2015-10-01)

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
by: Irini Chatziralli, et al.
Published: (2021-07-01)

Antivascular endothelial growth factor for macular oedema secondary to retinal vein occlusion: a systematic review and meta-analysis
by: Chao Zhang, et al.
Published: (2022-10-01)

Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan
by: Rai BB, et al.
Published: (2023-06-01)

Effect of intravitreal injection of anti-vascular endothelial growth factor agents on systemic concentration of vascular endothelial growth factor
by: Mei Wang, et al.
Published: (2023-04-01)

ON SOME NONTYPICAL DERIVATIONAL PROCESSES IN SERBIAN
by: Ковачевић Н. Борко
Published: (2023-12-01)

On the spectrum of a nontypical eigenvalue problem
by: Mihai Mihăilescu, et al.
Published: (2018-10-01)

Nontypical localization of pulmonary arteriovenous malformation
by: N. I. Fetisov, et al.
Published: (2017-08-01)